Slowdown casts doubt on biotech offerings

Slowdown casts doubt on biotech offerings
After a two-year capital drought, seven biotechnology and life sciences companies made initial public offerings in October and early this month. Now the newly issued stock of six of those companies is underwater — and one, Acusphere Inc. of Watertown, has lost 50 percent of its value since going public…

Biotechblog
Scroll to Top